STOCK ALARM
PRO
SA
PRO
Discover
Screener
Alerts
News
Portfolio
⌘
K
⌘
J
Pro
Sign In
Free Account
Themes
Moderna, Inc.
MRNA
NASDAQ
Loading
Overview
Intelligence
Charts
News
Fundamentals
Key Metrics
TTM
Financials
Earnings
Growth
Rating
Analysts
Institutional
Peers
Historical
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Income
Balance
Cash Flow
Annual
Quarterly
3Y
5Y
10Y
All
Revenue
$2B
↓39%
Gross Profit
$1B
↓38%
Operating Income
$-3B
↑22%
Net Income
$-3B
↑21%
EBITDA
$-3B
↑25%
EPS Diluted
-7.3
Cost of Revenue
$868M
Gross Margin %
55.3%
R&D Expenses
$3B
SG&A Expenses
$1B
Operating Expenses
$4B
Operating Margin %
-158.1%
Interest Expense
$0
Income Before Tax
$-3B
Income Tax Expense
$54M
Net Margin %
-145.2%
EPS
-7.3
Shares Out (Diluted)
389.0M
Shares Out (Basic)
389.0M
Total Costs & Expenses
$5B
Interest Income
$314M
EBITDA Margin %
-131.3%
Pre-Tax Margin %
-142.4%
Other Income/Expenses
$306M
Revenue CAGR (5Y)
+19.3%
Margin Trend
declining
Free Cash Flow
($2.1B)
Profitability
Unprofitable
Metric
Dec 21
Dec 22
Dec 23
Dec 24
Dec 25
Revenue
17,736
18,875
↑6.4%
6,848
↓63.7%
3,199
↓53.3%
1,944
↓39.2%
Gross Profit
15,119
13,459
↓11.0%
2,155
↓84.0%
1,735
↓19.5%
1,076
↓38.0%
Operating Income
13,296
9,420
↓29.2%
-4,239
↓145.0%
-3,945
↑6.9%
-3,074
↑22.1%
Net Income
12,202
8,362
↓31.5%
-4,714
↓156.4%
-3,561
↑24.5%
-2,822
↑20.8%
EBITDA
13,528
9,768
↓27.8%
-3,283
↓133.6%
-3,394
↓3.4%
-2,553
↑24.8%
EPS Diluted
28.29
20.10
↓29.0%
-12.34
↓161.4%
-9.27
↑24.9%
-7.26
↑21.7%
Show all metrics
← Newer
1 / 2
Older →
Values in millions except EPS · Ratios shown as percentages